Mankind Pharma Limited (BOM:543904)
2,244.95
-2.70 (-0.12%)
At close: Mar 2, 2026
-1.97% (1Y)
| Market Cap | 926.95B |
| Revenue (ttm) | 139.14B |
| Net Income (ttm) | 17.79B |
| Shares Out | n/a |
| EPS (ttm) | 43.10 |
| PE Ratio | 52.10 |
| Forward PE | 39.79 |
| Dividend | 1.00 (0.04%) |
| Ex-Dividend Date | Aug 8, 2025 |
| Volume | 39,732 |
| Average Volume | 19,929 |
| Open | 2,060.35 |
| Previous Close | 2,247.65 |
| Day's Range | 2,060.35 - 2,251.30 |
| 52-Week Range | 2,014.85 - 2,726.75 |
| Beta | n/a |
| RSI | 63.44 |
| Earnings Date | Feb 3, 2026 |